University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Efficacy of Varenicline for Smokeless Tobacco Use in India

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Drug: Varenicline
Behavioral: Counseling

First Posted Date: 2010-04-02

Last Posted Date: 2015-07-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 237

Registration Number: NCT01098305

Locations: 🇮🇳
All India Institute of Medical Research, New Dehli, India

Integrating Depression Services Into DM Management

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus
Depression

Interventions: Behavioral: Adherence Intervention

First Posted Date: 2010-04-02

Last Posted Date: 2012-03-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 182

Registration Number: NCT01098253

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Observational Study of Control Participants for the MAPP Research Network

Completed

Conditions: Fibromyalgia
Fatigue Syndrome, Chronic
Irritable Bowel Syndrome

First Posted Date: 2010-04-02

Last Posted Date: 2014-12-10

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 615

Registration Number: NCT01098292

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Stanford University, Stanford, California, United States

and more 5 locations

Rhodiola Rosea Therapy of Major Depressive Disorder

Phase 3

Completed

Conditions: Depression

Interventions: Dietary Supplement: Herbal extract
Other: Lactose monohydrate
Drug: Sertraline

First Posted Date: 2010-04-02

Last Posted Date: 2018-02-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 58

Registration Number: NCT01098318

Locations: 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Not Applicable

Completed

Conditions: Systemic Sclerosis
Scleroderma

Interventions: Drug: Ambrisentan

First Posted Date: 2010-03-26

Last Posted Date: 2018-11-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 15

Registration Number: NCT01093885

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Long Term Chamomile Therapy for Anxiety

Phase 3

Completed

Conditions: Generalized Anxiety Disorder

Interventions: Drug: Chamomile (Matricaria recutita)

First Posted Date: 2010-02-22

Last Posted Date: 2017-07-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 180

Registration Number: NCT01072344

Locations: 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States

Behavioral Economics and Food Choice

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: Calorie information
Behavioral: Exercise Equivalent only
Behavioral: Calorie & Exercise equivalent information

First Posted Date: 2010-02-03

Last Posted Date: 2011-11-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT01061905

Locations: 🇺🇸
ARAMARK healthcare at Main Line Health, Bryn Mawr, Pennsylvania, United States
🇺🇸
ARAMARK Healthcare at Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸
ARAMARK healthcare at North Shore University Health System, Evanston, Illinois, United States

and more 1 locations

Ovarian Freezing Before Cancer Treatment

Terminated

Conditions: Effects of Chemotherapy

First Posted Date: 2010-01-27

Last Posted Date: 2021-04-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 31

Registration Number: NCT01057745

Locations: 🇺🇸
Penn Fertility Care, 3701 Market Street, Suite 800, Philadelphia, Pennsylvania, United States

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Phase 4

Completed

Conditions: Parkinson Disease
Impulse Control Disorder

Interventions: Drug: Placebo
Drug: Naltrexone

First Posted Date: 2010-01-20

Last Posted Date: 2015-08-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 50

Registration Number: NCT01052831

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel

Not Applicable

Completed

Conditions: Combat Disorders
Posttraumatic Stress Disorders

Interventions: Behavioral: Prolonged Exposure Therapy - Massed
Behavioral: Present-Centered Therapy
Behavioral: Minimal Contact Control
Behavioral: Prolonged Exposure Therapy - Spaced

First Posted Date: 2010-01-14

Last Posted Date: 2018-11-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 366

Registration Number: NCT01049516

Locations: 🇺🇸
Carl R. Darnall Army Medical Center, Killeen, Texas, United States
🇺🇸
Center for the Treatment and Study of Anxiety, University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy